Is blood pressure reduction a valid surrogate endpoint for stroke prevention? an analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the biomarker-surrogacy (BioSurrogate) evaluation schema (BSES)

BACKGROUND: Blood pressure is considered to be a leading example of a valid surrogate endpoint. The aims of this study were to (i) formally evaluate systolic and diastolic blood pressure reduction as a surrogate endpoint for stroke prevention and (ii) determine what blood pressure reduction would pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lassere, Marissa N, Johnson, Kent R, Schiff, Michal, Rees, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388460/
https://www.ncbi.nlm.nih.gov/pubmed/22409774
http://dx.doi.org/10.1186/1471-2288-12-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388460/
https://www.ncbi.nlm.nih.gov/pubmed/22409774
http://dx.doi.org/10.1186/1471-2288-12-27

Ejemplares similares